Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: A possible explanation for impaired collateral formation in cardiac tissue

Circulation

Volumn 105, Issue 3, 2002, Pages 373-379

  Chou, Eva ^a   Suzuma, Izumi ^a   Way, Kerrie J ^a   Opland, Darren ^a   Clermont, Allen C ^a   Naruse, Keiko ^a   Suzuma, Kiyoshi ^a   Bowling, Nancy L ^a   Vlahos, Chris J ^a   Aiello, Lloyd Paul ^a   King, George L ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

Collateral circulation; Diabetes mellitus; Growth substances; Insulin; Myocardium

Indexed keywords

GROWTH PROMOTOR; INSULIN; RUBOXISTAURIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY LEAK SYNDROME; COLLATERAL CIRCULATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLOMERULUS; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; HUMAN TISSUE; HYPOXIA; INSULIN RESISTANCE; INSULIN TREATMENT; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA NEOVASCULARIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELLS, CULTURED; COLLATERAL CIRCULATION; CORONARY CIRCULATION; DIABETES MELLITUS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY GLOMERULUS; LYMPHOKINES; MALE; MIDDLE AGED; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RETINA; RNA, MESSENGER; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037154304     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0302.102143     Document Type: Article

References (31)

1. The Wisconsin epidemiologic study of diabetic retinopathy, XVIL: The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes
2. Effect of diabetes mellitus on formation of coronary collateral vessels
3. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
4. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
5. Insulin sensitivity in subjects with type 2 diabetes: Relationship to cardiovascular risk factors: The insulin resistance atherosclerosis study
6. The biology of vascular endothelial growth factor
7. Vascular endothelial growth factor induced by hypoxia may meditate hypoxia-initiated angiogenesis
8. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
9. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
10. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues
11. Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor
12. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent
13. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
14. Advanced glycation end products increase retinal vascular endothelial growth factor expression
15. VEGFs, receptors and angiogenesis
16. Early expression of angiogenesis factors in acute myocardial ischemia and infarction
17. Hypoxia, HIF-1, and the pathophysiology of common human diseases
18. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat
19. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes
20. Amelioration of vascular dysfunctions in diabetic rats by oral PKC beta inhibitor
21. Cyclic stretch and hypertension induce retinal VEGF and VEGF-R2 (KDR) expression: Potential mechanisms for exacerbation of diabetic retinopathy
22. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats
23. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells
24. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor
25. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatdylinositol 3 OH-kinase/AKT/Nitric oxide pathway and modulates migration of brain microvascular endothelial cells
26. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt-1, and P13-kinase-Akt dependent pathways in retinal vascular cells
27. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes
28. Interindividual heterogeneity in the hypoxic regulation of VEGF: Significance for the development of the coronary artery collateral circulation
29. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro
30. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth
31. Insulin and insulin-like growth factor-1 induce vascular endothelial growth factor mRNA expression via different signaling pathways